AKTX Forecast and Technical Stock Analysis
Hold candidate since 2019-12-12 Loss -0.53% PDF
Akari Therapeutics Plc fell by -0.53% in the last day ( Friday, 13th Dec 2019 ) from $1.90 to $1.89 and has now fallen 3 days in a row. During the day the stock fluctuated 3.24% from a day low at $1.85 to a day high of $1.91. The price has fallen in 5 of the last 10 days and is down by -8.25% for this period. Volume fell in the last day along with the stock, which is actually a good sign as volume should follow the stock. In the last day the trading volume fell by -32 798 shares and in total 195 932 shares bought and sold for approximately $370 311.00.
- 30 day high of the AKTX stock price was $2.64 and low was $1.78.
- 90 day high was $2.64 and low was $1.65.
- 52 week high for Akari Therapeutics Plc - $9.20 and low - $1.56.
Akari Therapeutics Plc lies in the middle of a wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 3.89% during the next 3 months and, with 90% probability hold a price between $1.81 and $2.26 at the end of this period.
Akari Therapeutics Plc holds a sales signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock. On further gains, the stock will meet resistance from the short-term moving average at approximately $1.93. On a fall, the stock will find some support from the long-term average at approximately $1.88. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sales signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sales signal was issued from a pivot top point on Monday December 02, 2019, which indicates further falls until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.
Relative Strength Index (RSI)
RSImin/max Values: [ 20 - 80 ]
RSI14 is 54 and the stock is currently not being overbought or oversold
* Stockinvest.us uses dynamical calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behaviour.
Support & Resistance
Akari Therapeutics Plc finds support from accumulated volume at $1.88.
This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.06 between high and low, or 3.24%. For the last week the stock has had a daily average volatility of 4.32%.
Our recommended stop-loss: $1.77 (-6.48%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from pivot top found 9 day(s) ago.)
4.32 %Average volatility
Very Low Low Medium High Very High
Akari Therapeutics Plc holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as hold candidate (hold or accumulate) in this position whilst awaiting further development.
|AKTX $1.89 ($-0.01 -0.53%)|
AKTX is down $0.01 today, but where's it headed in 2020?
|Zacks Investment Research is releasing its prediction for AKTX based on the 1-3 month system that more than doubles the S&P 500.
This report is free today for StockInvest.us readers.
Click here – the AKTX analysis is free »
Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!